TY  - CONF

T1  - Long-term dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to- severe atopic dermatitis in an open-label extension study

JO  - PEDIATRIC ALLERGY AND IMMUNOLOGY

PY  - 2024/01/01

AU  - Paller AS

AU  - Ramien M

AU  - Cork MJ

AU  - Simpson EL

AU  - Lee LW

AU  - Eichenfield LF

AU  - Silva D

AU  - Coleman A

AU  - Gherardi G

AU  - Chen Z

AU  - Zhang A et al

ED  - 

VL  - 35

Y2  - 2025/04/27

ER  -